Motivations
As neurodegenerative disorders rise, there is a clear need for early-onset therapy and prevention. With the recent improvements in diagnostic technologies, a new standard of care is available. BrainTrain dawns at the new age of digital therapeutics. In this new age, treatments rely on the electromagnetic nature of the human body. This allows for patient-specific treatment and optimization with minimal side effects compared to current standards of care.


